Spots Global Cancer Trial Database for A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
Official Title: A Phase I/ II Study of Hypofractionated Radiotherapy With Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients Over 70 Years Old With Newly Diagnosed Glioblastoma
Study ID: NCT01985087
Conditions
Study Description
Brief Summary: In this study we propose to determine outcomes of patients age 70 or older treated with radiation over 2 weeks given with temozolomide 75 mg/m2 daily during radiotherapy and as a post radiation treatment of 150 mg/m2 - 200 mg /m2 for 6 cycles or until the disease progresses.
Detailed Description:
Keywords
Eligibility
Minimum Age: 70 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Contact Details
Name: Shiao Woo, MD
Affiliation: James Graham Brown Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
